Indeed, knockdown or inhibition of PLK1 [77], CDK1 [78], AURKA [79], MELK [80,81], and NEK2 [82] resulted in reduction or repression of metastatic potential and invasiveness of various cancer types, including mCRPC and cervical cancer. Here, NEK2 is linked to cervical cancer.